Pharmaceutical

Basilea's Toctino(R) (alitretinoin) receives first national marketing authorization in the UK

GENEART Founds a Subsidiary in the West Coast of the US

Medistem Inc. announced today that it has modified an existing license agreement with the Institute for Cellular Medicine .

WellPoint today announced revised medical and pharmacy guidelines to help members who are directly impacted by Hurricane Ike. In addition, a 24-hour nurse helpline - 1-866-417-7107 - has been established to assist members.

Genomic Health, Inc. today announced results from two studies demonstrating that quantitative reporting for HER2 gene expression, as measured by the company's Oncotype DX breast cancer assay, has a high degree of concordance with both fluorescence in sit

CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 w

Cell Therapeutics, Inc. announced that today, the Company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company is not in compliance with the $50,000,000 minimum market value of listed securiti

In the news release, The Decline of Males, Why They Die First; at White Plains Hospital September 17, issued earlier today, the source should read "Ad hoc committee of members of the Westchester medical and psychiatric societies" rather than &q